All In Biotech

Drug Trial Radar · NCT07065331

A Study of Inhaled AZD8630 in Adolescents With Asthma

A Phase I, Open-label, Single-dose Study to Evaluate the Pharmacokinetics of Inhaled AZD8630 in Adolescents With Asthma

Last checked: Nov 19, 2026Latest source record: Oct 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

10

Actual

Start

Jun 11, 2025

Primary completion

Sep 19, 2025

Study completion Sep 19, 2025

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Jul 15, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the pharmacokinetic (PK) profile, safety, tolerability, and immunogenicity of single inhaled dose of AZD8630 administered in adolescent participants with asthma as well as the safety and performance of the dry powder inhaler.

Conditions

  • Asthma

Interventions

  • AZD8630Drug

    Single inhaled dose of AZD8630 via dry powder inhaler.

  • Dry powder inhalerDevice

    Single inhaled dose of AZD8630 via dry powder inhaler.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area under the serum concentration-time curve from time zero to 24 hours (AUC0-24)Time frame: Up to Day 9
  2. Maximum observed drug concentration (Cmax)Time frame: Up to Day 9
  3. Time to reach peak or maximum observed concentration (Tmax)Time frame: Up to Day 9

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Bakersfield, California

  • Research Site

    Miami Lakes, Florida

  • Research Site

    Lafayette, Louisiana

  • Research Site

    Raleigh, North Carolina

  • Research Site

    Toledo, Ohio

  • Research Site

    Oklahoma City, Oklahoma

  • Research Site

    Spartanburg, South Carolina

  • Research Site

    Boerne, Texas

  • Research Site

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.